MARIN’s IDN Research provides in-depth intelligence on one of the most complex and influential customer segments in healthcare. As integrated delivery networks (IDNs) continue to expand their impact on oncology drug utilization, prescribing practices, and financial management, understanding their strategies is critical for pharmaceutical manufacturers.
With tailored strategies for oncologists and pharmacists, our research empowers you to optimize product positioning, refine engagement tactics, and adapt to IDNs’ evolving market dynamics.
Offering color
#89f5d1 1